Compound 21, a selective agonist of angiotensin AT(2) receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo

Amanda K. Sampson, Jennifer C. Irvine, Waled A. Shihata, Dragana Dragoljevic, Natalie Lumsden, Olivier Huet, Tyrone Barnes, Thomas Unger, Ulrike M. Steckelings, Garry L. Jennings, Robert E. Widdop, Jaye P. F. Chin-Dusting

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)729-740
JournalBritish Journal of Pharmacology
Volume173
Issue number4
DOIs
Publication statusPublished - Feb 2016

Cite this

Sampson, A. K., Irvine, J. C., Shihata, W. A., Dragoljevic, D., Lumsden, N., Huet, O., Barnes, T., Unger, T., Steckelings, U. M., Jennings, G. L., Widdop, R. E., & Chin-Dusting, J. P. F. (2016). Compound 21, a selective agonist of angiotensin AT(2) receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. British Journal of Pharmacology, 173(4), 729-740. https://doi.org/10.1111/bph.13063